Human Growth Hormone (HGH) Peptide Therapy
Your Trusted Source For HGH Peptides
What is HGH peptide therapy?
HGH Peptide therapy refers to the clinical use of short chains of amino acids, known as peptides, that may interact with specific receptors in the body to support normal physiological processes. Certain peptides function as growth hormone–releasing agents (also known as secretagogues), which stimulate the body’s own production of growth hormone rather than supplying exogenous human growth hormone (HGH).
Growth hormone plays an important role in normal metabolism, tissue maintenance, and overall physiological regulation. Endogenous growth hormone production naturally declines with age, which may contribute to changes in body composition and recovery capacity. Evaluation of growth hormone status is based on clinical assessment and appropriate laboratory testing.
Because recombinant human growth hormone (rhGH) is tightly regulated, expensive, and approved only for specific medical conditions, Alpha Hormones® does not prescribe or dispense HGH for non-approved uses. Instead, when clinically appropriate and within regulatory guidelines, patients may be evaluated for FDA-approved therapies or for non-HGH peptide agents that support endogenous growth hormone signaling.
Peptides such as sermorelin and tesamorelin are not human growth hormone. Tesamorelin is FDA-approved for a specific indication in HIV-associated lipodystrophy, and sermorelin has historically been used to evaluate or stimulate pituitary growth hormone release. Any consideration of peptide therapy is based on individual clinical evaluation, medical necessity, and applicable regulatory standards.
This information is provided for educational purposes only and does not constitute medical advice or a guarantee of therapeutic benefit. All treatments offered by Alpha Hormones® are determined on a case-by-case basis and prescribed only when medically appropriate and compliant with federal and state regulations.
Symptoms of HGH deficiency include:
- Loss of muscle mass
- Decreased overall strength and endurance
- Slow recovery time after physical activity
- Low energy
- Brain fog
- Decreased cognitive function
- Higher body fat concentrated in the waist
- Hair loss
- Lose of skin elasticity and wrinkles
- Problems with sexual function
- Poor quality of sleep
- Decreased bone density and prone to fractures
Peptide Therapy For HGH Secretion
Sermorelin
Sermorelin is a synthetic peptide that was approved by the U.S. Food and Drug Administration (FDA) in 1997 for use in the diagnosis of growth hormone deficiency in children. It is a growth hormone–releasing hormone (GHRH) analog consisting of the first 29 amino acids of endogenous GHRH. Through this mechanism, sermorelin stimulates the pituitary gland to release growth hormone by activating normal physiologic signaling pathways, which is why it is commonly described as a growth hormone “secretagogue.”
Rather than supplying exogenous human growth hormone (HGH), sermorelin promotes the body’s endogenous growth hormone production, resulting in a pulsatile release pattern that more closely resembles normal physiology. Because of this mechanism, sermorelin has been studied as an alternative approach to supporting pituitary signaling in select clinical contexts.
Research has explored sermorelin’s effects on metabolic regulation, body composition, and recovery processes by influencing growth hormone pathways; however, many uses discussed in wellness or anti-aging settings have not been established through large-scale clinical trials and are considered investigational. Clinical responses may vary among individuals.
As with any peptide-based therapy, sermorelin should be considered only under the supervision of a licensed medical provider, with careful evaluation of medical history, appropriate clinical indications, and an understanding of the current limitations of available evidence.
Tesamorelin
Tesamorelin is a growth hormone–releasing factor (GRF) analog that is FDA-approved and marketed under the brand name Egrifta®. It is approved specifically for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Tesamorelin acts by stimulating pituitary somatotroph cells to release endogenous growth hormone in a pulsatile, physiologic pattern. This process results in an increase in insulin-like growth factor-1 (IGF-1), which is involved in metabolic regulation.
As a GRF analog, tesamorelin supports the body’s natural growth hormone secretion rather than providing exogenous human growth hormone (HGH). Its effects on visceral adipose tissue have been established only within its FDA-approved patient population.
Use of tesamorelin outside of its approved indication—including for general weight loss, anti-aging, or wellness purposes—has not been established through FDA approval and remains investigational. Any consideration of tesamorelin therapy should occur under the supervision of a licensed medical provider, with appropriate clinical evaluation and a clear understanding of its approved uses, potential risks, and regulatory limitations.
Benefits of HGH secretagogues may include:
- Increase protein synthesis
- Promote fat break down
- Improve sleep quality
- Increase bone density
- Accelerate injury recovery
- Improve immune system
- Increase protein synthesis
- Increase energy
- Increase IGF-1
- Increase in lean body mass
Some patients explore growth hormone–releasing peptides out of interest in their potential role in supporting normal physiologic processes related to sleep regulation, energy balance, cognitive function, and skin health. Individual responses can vary, and these effects have not been established in all individuals or across all clinical settings.
At Alpha Hormones®, our medical providers conduct a comprehensive review of each patient’s health questionnaire, medical history, and relevant laboratory data to develop an individualized understanding of overall health. Any consideration of peptide therapy is based on clinical appropriateness, patient-specific factors, and current medical evidence, and is determined on a case-by-case basis.
What You Can Expect With Optimal HGH Level
Week 1
Quality of Sleep
Week 2
Recovery from workouts
Week 3
Mental Clarity
Week 4
Skin Elasticiy
Week 5
Body Composition
Here is a list of the gradual improvements one would experience with HGH Peptide Therapy
First Month:
- Vivid dreams better
- Sounder sleep
- Improved stamina
- Optimistic attitude
Second Month:
- Improved muscle tone
- Increased strength
- Improved skin tone
- Improved nail growth
- Better digestion
- Improved vision
- Enhanced sexual function
Third Month:
- Improved mental processes
- Enhanced productivity
- Faster wound healing
- Hair re-growth
- Increased libido
- Increased muscle size
- Faster recovery from muscle soreness
- Reduced PMS symptoms
- Greater body flexibility
- Reduced pain
Fourth Month:
- Heightened improvements with all of the above
- At times improvements may seem to diminish or plateau
- Rejuvenation is still a process
- Benefits should resume with continued improvements.
Fifth Month:
- Improved weight loss and reduction of inches
- Improved skin texture and appearance
- Skin thickening and greater elasticity
- Reduction of skin wrinkles
- Thickening of hair with a shiny, healthy appearance
Sixth Month:
- Diminished cellulite
- Improved eyesight
- Improved body contour
- Improved resistance to colds, flu and other illnesses
- Healing of old wounds
- Disappearance of pain and soreness
HGH peptide therapy is a great way to increase your GH and IGF-1 levels. There are many benefits by optimizing HGH level, talk to the hormone expert and find out if this therapy is right for you.
